Product review of Aurora FirstLight (sources - content & coverage)
26th January 2018

In part two of Jinfo's product review of Aurora's FirstLight, we highlight the product's sources, including news databases, company financials, as well as access to LexisNexis Metabase content. It also lists the product's languages and geographical coverage.

Note: Full review (PDF) at /go/sub/report/2937

Read

Product review of Aurora FirstLight
25th January 2018

Read

Product review of Aurora FirstLight (key advantages; introduction; contact details)
25th January 2018

FirstLight is a Software as a Service (SaaS) product that uses machine-learning algorithms to mine a variety of public and private data sources which organisations can use to make better and more informed decisions. In part one of Jinfo's review, we introduce the company and platform, its audience, key advantages, value and development plans.

Note: Full review (PDF) at /go/sub/report/2937

Read

Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
24th January 2018

In the final part of our product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs, we look at the help and training that's available to users along with detailed pricing information. We also highlight the value of the product and how it can be used as a business analysis tool rather than just be used for patent searching, and where it sits against competitor or complementary products such as Cortellis, Clarivate and AdisInsight.

Note: Full review (PDF) at /go/sub/report/2934

Read

Market landscape - expert networks for investment banking professionals
24th January 2018

Read

Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
23rd January 2018

The third part of Jinfo's product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs, we highlight the search interface and functionality, provide a detailed look at the content and sources available in the product, typical use-cases as well as outputs and alerts available and its administrative capabilities.

Note: Full review (PDF) at /go/sub/report/2934

Read

Product review of DrugPatentWatch (sources - content & coverage)
22nd January 2018

In part two of our product review of DrugPatentWatch, a database which provides patent information from the US and worldwide along with other actionable business intelligence on small-molecule drugs, we take a look at its strengths and weaknesses and content and sources.

Note: Full review (PDF) at /go/sub/report/2934

Read

Building the mosaic - resources used inside buy-side funds to support the investment process
19th January 2018

The process of building an investment case within a buy-side fund is often thought of as being like piecing together a mosaic from many tiny fragments of information. This article provides a whistle-stop tour through a range of resources commonly used by firms to help their analysts find the relevant pieces.

Read

Product review of DrugPatentWatch (key advantages; introduction; contact details)
19th January 2018

We carry out an in-depth product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs and patents and was founded by Yali Friedman, named one of the 100 most influential people in biotechnology. Part one of the review introduces the product and company behind it, along with its key advantages, competitors and how the product is likely to evolve.

Note: Full review (PDF) at /go/sub/report/2934

Read

Product review of DrugPatentWatch
19th January 2018

Read